Theriva Biologics, Inc.
TOVX$6M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaROCKVILLE
Drugs in Pipeline
4
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
TOVX News
Catalyst Timeline
0 upcoming, 1 past
No catalysts found.
Drug Pipeline
Period 1 - Treatment Sequence AB
Healthy Volunteers
SYN-004
Healthy Volunteers With Ileostomy
SYN-010
Irritable Bowel Syndrome With Constipation (IBS-C)
SYN-010 21 mg
Irritable Bowel Syndrome With Constipation (IBS-C)
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Period 1 - Treatment Sequence AB | Phase 2 | Healthy Volunteers | - | - |
SYN-004 | Phase 2 | Healthy Volunteers With Ileostomy | - | - |
SYN-010 | Phase 2 | Irritable Bowel Syndrome With Constipation (IBS-C) | - | - |
SYN-010 21 mg | Phase 2 | Irritable Bowel Syndrome With Constipation (IBS-C) | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply